IRCT20160523028008N14
Not yet recruiting
Phase 2
The effect Dehydroepiandrosterone (DHEA) supplementation on IVF outcome
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hamedan University of Medical Sciences
- Enrollment
- 80
- Status
- Not yet recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Candidates for IVF over 35 years
- •Body mass index between 18 and 25 (kg/m^2\)
- •FSH hormone levels less than 10 IU /
Exclusion Criteria
- •Systemic diseases such as diabetes, thyroid diseases
- •History of ovarian surgery
- •History of receiving DHEA
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effect of dehydroepiandrosterone on quality of liferheumatoid arthritis.Seropositive rheumatoid arthritisIRCT2017052134062N1Vice chancellor for research, Zahedan University of Medical Sciences46
Completed
Phase 2
Effects of Dehydroepiandrosterone on ovary.IRCT2017091529374N1Vice chancellor of Mazandaran University of Medical Science.70
Completed
Not Applicable
DHEA Replacement in Adrenalectomized/Hypoadrenal PatientsAgingDehydroepiandosterone ReplacementDHEA ReplacementNCT00279929Mayo Clinic32
Recruiting
Phase 4
Role of a natural hormone supplement in improving pregnancy rate.Health Condition 1: N972- Female infertility of uterine originCTRI/2020/06/025918CRAFT Hospital and Research Centre
Completed
Not Applicable
Immune effects of dehydroepiandrosterone (DHEA) in adrenal insufficiency (IDHEAL)ISRCTN18758725Department of Health50